Global eClinical Solutions Market – Industry Trends and Forecast to 2026
- DAT3308068
- 203 Pages
- October 2019
- Healthcare
Market Segmentation:
By Product {Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTSM), Clinical Trial Management Systems (CTMS), Electronic Clinical Outcome Assessment (ECOA), Electronic Trial Master File Systems, Safety Solutions, Regulatory Information Management Solutions, Clinical Data Integration Platforms, Other eClinical Solutions}, Deployment {Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions, Licensed Enterprise (On-Premise) Solutions}, Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), End User {Hospital/Healthcare Provider, Contract Research Organizations (CROS), Pharma & Biotech Organizations, Medical Device Manufacturers, Consulting Service Companies, Academic Institutes}, Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Some of the major factors contributing to the growth of the market:
• Increasing adoption of clinical trials
• Increasing life sciences R&D expenditure
• Rising government initiatives
Market Players:
The key market players for global eClinical solutions market are listed below:
• Parexel International Corporation
• Oracle
• Medidata Solutions, Inc.
• Veeva Systems
• ERT Clinical
• eClinical Solutions LLC
• IBM Corporation
• eClinicalWorks
• Bioclinica
• ArisGlobal
• Advarra
• Anju Software, Inc.
• Bio-Optronics, Inc.
• DATATRAK Int.
• ICON plc
• MasterControl, Inc.
• MaxisIT
• OmniComm Systems, Inc.
• RESONANCE HEALTH
• The Realtime Group
• Signant Health
• Xybion Corporation
• Others
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF GLOBAL ECLINICAL SOLUTIONS MARKET 21
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 23
2 MARKET SEGMENTATION 25
2.1 MARKETS COVERED 25
2.2 GLOBAL ECLINICAL SOLUTIONS MARKET: GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 CURRENCY AND PRICING 27
2.5 DBMR TRIPOD DATA VALIDATION MODEL 28
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
2.7 DBMR MARKET POSITION GRID 32
2.8 MULTIVARIATE MODELING 33
2.9 PRODUCTS LIFELINE CURVE 33
2.10 SECONDARY SOURCES 34
2.11 ASSUMPTIONS 34
3 MARKET OVERVIEW 35
3.1 DRIVERS 37
3.1.1 INCREASING ADOPTION OF CLINICAL TRIALS 37
3.1.2 RISING GOVERNMENT INITIATIVES 39
3.1.3 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATION 40
3.1.4 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 41
3.2 RESTRAINTS 44
3.2.1 DEARTH OF TRAINED PROFESSIONALS 44
3.2.2 HIGH IMPLEMENTATION COST 45
3.3 OPPORTUNITIES 46
3.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 46
3.3.2 TECHNOLOGICAL ADVANCEMENT 47
3.4 CHALLENGES 48
3.4.1 STRINGENT REGULATIONS 48
4 EXECUTIVE SUMMARY 49
5 PREMIUM INSIGHTS 51
6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT 53
6.1 OVERVIEW 54
6.2 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) 55
6.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) 56
6.4 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) 56
6.5 ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) 57
6.6 ELECTRONIC TRIAL MASTER FILE SYSTEM 57
6.7 SAFETY SOLUTIONS 58
6.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 58
6.9 CLINICAL DATA INTEGRATION PLATFORMS 59
6.10 CLINICAL ANALYTICS PLATFORMS 59
6.11 OTHER ECLINICAL SOLUTIONS 60
7 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE 61
7.1 OVERVIEW 62
7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 63
7.3 CLOUD-BASED (SAAS) SOLUTIONS 63
7.4 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS 64
8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 65
8.1 OVERVIEW 66
8.2 PHASE III 67
8.3 PHASE II 67
8.4 PHASE IV 68
8.5 PHASE I 68
9 GLOBAL ECLINICAL SOLUTIONSMARKET, BY END USER 69
9.1 OVERVIEW 70
9.2 HOSPITALS/HEALTHCARE PROVIDERS 71
9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) 72
9.4 ACADEMIC INSTITUTES 72
9.5 PHARMA & BIOTECH ORGANIZATIONS 73
9.6 MEDICAL DEVICE MANUFACTURERS 73
9.7 CONSULTING SERVICE COMPANIES 74
10 GLOBAL ECLINICAL SOLUTIONS MARKET, BY GEOGRAPHY 75
10.1 OVERVIEW 76
10.2 NORTH AMERICA 81
10.2.1 U.S. 86
10.2.2 CANADA 88
10.2.3 MEXICO 90
10.3 EUROPE 92
10.3.1 GERMANY 97
10.3.2 U.K. 99
10.3.3 ITALY 101
10.3.4 FRANCE 103
10.3.5 RUSSIA 105
10.3.6 SWITZERLAND 107
10.3.7 NETHERLANDS 109
10.3.8 SPAIN 111
10.3.9 TURKEY 113
10.3.10 BELGIUM 115
10.3.11 REST OF EUROPE 117
10.4 ASIA-PACIFIC 118
10.4.1 JAPAN 123
10.4.2 CHINA 125
10.4.3 INDIA 127
10.4.4 SOUTH KOREA 129
10.4.5 AUSTRALIA 131
10.4.6 SINGAPORE 133
10.4.7 THAILAND 135
10.4.8 MALAYSIA 137
10.4.9 INDONESIA 139
10.4.10 PHILIPPINES 141
10.4.11 REST OF ASIA-PACIFIC 143
10.5 SOUTH AMERICA 144
10.5.1 BRAZIL 149
10.5.2 REST OF SOUTH AMERICA 151
10.6 MIDDLE EAST AND AFRICA 152
10.6.1 SOUTH AFRICA 157
10.6.2 REST OF MIDDLE EAST AND AFRICA 159
11 GLOBAL ECLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE 160
11.1 COMPANY SHARE ANALYSIS: GLOBAL 160
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 161
11.3 COMPANY SHARE ANALYSIS: EUROPE 162
11.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC 163
12 COMPANY PROFILE 164
12.1 ORACLE 164
12.1.1 COMPANY SNAPSHOT 164
12.1.2 REVENUE ANALYSIS 164
12.1.3 COMPANY SHARE ANALYSIS 165
12.1.4 PRODUCT PORTFOLIO 165
12.1.5 RECENT DEVELOPMENTS 165
12.2 MEDIDATA SOLUTIONS 166
12.2.1 COMPANY SNAPSHOT 166
12.2.2 REVENUE ANALYSIS 166
12.2.3 COMPANY SHARE ANALYSIS 167
12.2.4 PRODUCT PORTFOLIO 167
12.2.5 RECENT DEVELOPMENT 167
12.3 PAREXEL INTERNATIONAL CORPORATION 168
12.3.1 COMPANY SNAPSHOT 168
12.3.2 COMPANY SHARE ANALYSIS 168
12.3.3 PRODUCT PORTFOLIO 169
12.3.4 RECENT DEVELOPMENTS 169
12.4 BIOCLINICA 170
12.4.1 COMPANY SNAPSHOT 170
12.4.2 PRODUCT PORTFOLIO 170
12.4.3 RECENT DEVELOPMENTS 171
12.5 ERT CLINICAL 172
12.5.1 COMPANY SNAPSHOT 172
12.5.2 PRODUCT PORTFOLIO 172
12.5.3 RECENT DEVELOPMENTS 172
12.6 ARIS GLOBAL 173
12.6.1 COMPANY SNAPSHOT 173
12.6.2 PRODUCT PORTFOLIO 173
12.6.3 RECENT DEVELOPMENTS 174
12.7 ADVARRA 175
12.7.1 COMPANY SNAPSHOT 175
12.7.2 PRODUCT PORTFOLIO 175
12.7.3 RECENT DEVELOPMENTS 176
12.8 ANJU SOFTWARE 177
12.8.1 COMPANY SNAPSHOT 177
12.8.2 PRODUCT PORTFOLIO 177
12.8.3 RECENT DEVELOPMENTS 177
12.9 BIO-OPTRONICS, INC 178
12.9.1 COMPANY SNAPSHOT 178
12.9.2 PRODUCT PORTFOLIO 178
12.9.3 RECENT DEVELOPMENTS 178
12.10 DATATRAK INT. 180
12.10.1 COMPANY SNAPSHOT 180
12.10.2 REVENUE ANALYSIS 180
12.10.3 SOLUTION PORTFOLIO 181
12.10.4 RECENT DEVELOPMENTS 181
12.11 ECLINICALWORKS 182
12.11.1 COMPANY SNAPSHOT 182
12.11.2 PRODUCT PORTFOLIO 182
12.11.3 RECENT DEVELOPMENTS 182
12.12 ECLINICAL SOLUTIONS LLC 183
12.12.1 COMPANY SNAPSHOT 183
12.12.2 PRODUCT PORTFOLIO 183
12.12.3 RECENT DEVELOPMENTS 183
12.13 IBM CORPORATION 184
12.13.1 COMPANY SNAPSHOT 184
12.13.2 REVENUE ANALYSIS 184
12.13.3 PRODUCT PORTFOLIO 185
12.13.4 RECENT DEVELOPMENT 185
12.14 ICON PLC 186
12.14.1 COMPANY SNAPSHOT 186
12.14.2 REVENUE ANALYSIS 186
12.14.3 SERVICE PORTFOLIO 186
12.14.4 RECENT DEVELOPMENTS 187
12.15 MASTERCONTROL, INC. 188
12.15.1 COMPANY SNAPSHOT 188
12.15.2 SOLUTION PORTFOLIO 188
12.15.3 RECENT DEVELOPMENTS 188
12.16 MAXISIT 189
12.16.1 COMPANY SNAPSHOT 189
12.16.2 PRODUCT PORTFOLIO 189
12.16.3 RECENT DEVELOPMENT 189
12.17 OMNICOMM SYSTEMS, INC 190
12.17.1 COMPANY SNAPSHOT 190
12.17.2 REVENUE ANALYSIS 190
12.17.3 PRODUCT PORTFOLIO 191
12.17.4 RECENT DEVELOPMENTS 191
12.18 RESONANCE HEALTH 192
12.18.1 COMPANY SNAPSHOT 192
12.18.2 REVENUE ANALYSIS 192
12.18.3 PRODUCT PORTFOLIO 193
12.18.4 RECENT DEVELOPMENTS 193
12.19 REALTIME 194
12.19.1 COMPANY SNAPSHOT 194
12.19.2 PRODUCT PORTFOLIO 194
12.19.3 RECENT DEVELOPMENT 194
12.20 SIGNANT HEALTH 195
12.20.1 COMPANY SNAPSHOT 195
12.20.2 SOLUTION PORTFOLIO 195
12.20.3 RECENT DEVELOPMENTS 195
12.21 VEEVA SYSTEMS 196
12.21.1 COMPANY SNAPSHOT 196
12.21.2 REVENUE ANALYSIS 196
12.21.3 COMPANY SHARE ANALYSIS 197
12.21.4 PRODUCT PORTFOLIO 197
12.21.5 RECENT DEVELOPMENT 197
12.22 XYBION CORPORATION 198
12.22.1 COMPANY SNAPSHOT 198
12.22.2 PRODUCT PORTFOLIO 198
12.22.3 RECENT DEVELOPMENTS 199
13 QUESTIONNAIRE 200
14 RELATED REPORTS 203
UU
TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS 37
TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE 43
TABLE 3 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 55
TABLE 4 GLOBAL ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 55
TABLE 5 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 56
TABLE 6 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 56
TABLE 7 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 57
TABLE 8 GLOBAL ELECTRICAL TRIAL MASTER FILE SYSTEM IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 57
TABLE 9 GLOBAL SAFETY SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 58
TABLE 10 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 58
TABLE 11 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 59
TABLE 12 GLOBAL CLINICAL ANALYTICS PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 59
TABLE 13 GLOBAL OTHER ECLINICAL SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 60
TABLE 14 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 62
TABLE 15 GLOBAL WEB-HOSTED (ON-DEMAND) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 63
TABLE 16 GLOBAL CLOUD-BASED (SAAS) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 63
TABLE 17 GLOBAL LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 64
TABLE 18 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 66
TABLE 19 GLOBAL PHASE III IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 67
TABLE 20 GLOBAL PHASE II IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 67
TABLE 21 GLOBAL PHASE IV IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 68
TABLE 22 GLOBAL PHASE I IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 68
TABLE 23 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 71
TABLE 24 GLOBAL HOSPITALS/HEALTHCARE PROVIDERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 71
TABLE 25 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 72
TABLE 26 GLOBAL ACADEMIC INSTITUTES COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 72
TABLE 27 GLOBAL PHARMA & BIOTECH ORGANIZATIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 73
TABLE 28 GLOBAL MEDICAL DEVICE MANUFACTURERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 73
TABLE 29 GLOBAL CONSULTING SERVICE COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 74
TABLE 30 GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 80
TABLE 31 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 84
TABLE 32 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 84
TABLE 33 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 84
TABLE 34 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 85
TABLE 35 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 85
TABLE 36 U.S. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 86
TABLE 37 U.S. ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 86
TABLE 38 U.S. ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 86
TABLE 39 U.S. ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 87
TABLE 40 CANADA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 88
TABLE 41 CANADA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 88
TABLE 42 CANADA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 88
TABLE 43 CANADA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 89
TABLE 44 MEXICO ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 90
TABLE 45 MEXICO ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 90
TABLE 46 MEXICO ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 90
TABLE 47 MEXICO ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 91
TABLE 48 EUROPE ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 95
TABLE 49 EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 95
TABLE 50 EUROPE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 96
TABLE 51 EUROPE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 96
TABLE 52 EUROPE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 96
TABLE 53 GERMANY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 97
TABLE 54 GERMANY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 97
TABLE 55 GERMANY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 97
TABLE 56 GERMANY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 98
TABLE 57 U.K. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 99
TABLE 58 U.K. ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 99
TABLE 59 U.K. ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 99
TABLE 60 U.K. ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 100
TABLE 61 ITALY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 101
TABLE 62 ITALY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 101
TABLE 63 ITALY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 101
TABLE 64 ITALY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 102
TABLE 65 FRANCE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 103
TABLE 66 FRANCE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 103
TABLE 67 FRANCE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 103
TABLE 68 FRANCE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 104
TABLE 69 RUSSIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 105
TABLE 70 RUSSIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 105
TABLE 71 RUSSIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 105
TABLE 72 RUSSIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 106
TABLE 73 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 107
TABLE 74 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 107
TABLE 75 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 107
TABLE 76 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 108
TABLE 77 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 109
TABLE 78 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 109
TABLE 79 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 109
TABLE 80 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 110
TABLE 81 SPAIN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 111
TABLE 82 SPAIN ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 111
TABLE 83 SPAIN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 111
TABLE 84 SPAIN ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 112
TABLE 85 TURKEY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 113
TABLE 86 TURKEY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 113
TABLE 87 TURKEY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 113
TABLE 88 TURKEY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 113
TABLE 89 BELGIUM ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 115
TABLE 90 BELGIUM ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 115
TABLE 91 BELGIUM ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 115
TABLE 92 BELGIUM ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 116
TABLE 93 REST OF EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 117
TABLE 94 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 121
TABLE 95 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 121
TABLE 96 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 122
TABLE 97 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 122
TABLE 98 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 122
TABLE 99 JAPAN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 123
TABLE 100 JAPAN ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 123
TABLE 101 JAPAN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 123
TABLE 102 JAPAN ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 124
TABLE 103 CHINA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 125
TABLE 104 CHINA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 125
TABLE 105 CHINA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 125
TABLE 106 CHINA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 126
TABLE 107 INDIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 127
TABLE 108 INDIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 127
TABLE 109 INDIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 127
TABLE 110 INDIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 127
TABLE 111 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 129
TABLE 112 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 129
TABLE 113 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 129
TABLE 114 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 130
TABLE 115 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 131
TABLE 116 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 131
TABLE 117 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 131
TABLE 118 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 132
TABLE 119 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 133
TABLE 120 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 133
TABLE 121 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 133
TABLE 122 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 134
TABLE 123 THIALAND ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 135
TABLE 124 THIALAND ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 135
TABLE 125 THIALAND ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 135
TABLE 126 THIALAND ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 136
TABLE 127 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 137
TABLE 128 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 137
TABLE 129 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 137
TABLE 130 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 138
TABLE 131 INDONESIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 139
TABLE 132 INDONESIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 139
TABLE 133 INDONESIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 139
TABLE 134 INDONESIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 140
TABLE 135 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 141
TABLE 136 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 141
TABLE 137 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 141
TABLE 138 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 142
TABLE 139 REST OF ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 143
TABLE 140 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 147
TABLE 141 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 147
TABLE 142 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 147
TABLE 143 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 148
TABLE 144 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 148
TABLE 145 BRAZIL ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 149
TABLE 146 BRAZIL ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 149
TABLE 147 BRAZL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 149
TABLE 148 BRAZIL ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 150
TABLE 149 REST OF SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 151
TABLE 150 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 155
TABLE 151 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 155
TABLE 152 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 155
TABLE 153 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 156
TABLE 154 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 156
TABLE 155 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 157
TABLE 156 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 157
TABLE 157 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 158
TABLE 158 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 158
TABLE 159 REST OF MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 159
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
